Abstract S90 Table 1

Headline Results by Year

Data Completeness
2005200620072008200920102011
Number of cases10,92016,92220,63925,75730,15830,32931,429
PS66%77%80%87%88%84%89%
Staging51%55%70%77%80%82%84%
Treatment66%72%79%82%89%89%91%
Process and Outcomes
2005200620072008200920102011
Confirmed Histological diagnosis68%66%65%66.7%69.5%76.5%73.8%
Histology
 NSCLC44.8%43.9%45.5%52.2%56%57%58.4%
 SCLC10.3%10%9.6%10.3%10.5%10.9%11.1%
 Mesothelioma3.7%3.5%4.2%4.4%5.0%5.5%5.2%
NSCLC NOS rate-36%32%33.6%30%24% *TBC
Discussed at MDT?79%84.3%86.8%88.6%93.2%96.1%95.9%
Any anti-cancer treatment?45%50%52%54%58.9%58.5%60.5%
Overall surgical resection rate9%9.4%10.3%11.2%13.9%13.9%15.3%
NSCLC resection rate13.8%14.3%15.2%16%19%18.3%21%
SCLC chemotherapy rate57.7%61.7%64.5%63%66%65%68%
1 year survival35.5%35.0%34.6%34.7%35.2%35.8% *TBC
Seen by LCNS---50.9%64.4%75.5%79.4%
LCNS at diagnosis---28.5%41%51.9%58.7%
  • * TBC=to be confirmed; LCNS=lung cancer specialist nurse; NOS=not otherwise specified.